FDA.reportPublic FDA data

Application 213232

Type
ANDA
Sponsor
CAPLIN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001VERAPAMIL HYDROCHLORIDEVERAPAMIL HYDROCHLORIDESOLUTION;INTRAVENOUS5MG/2ML (2.5MG/ML)NoNo
002VERAPAMIL HYDROCHLORIDEVERAPAMIL HYDROCHLORIDESOLUTION;INTRAVENOUS10MG/4ML (2.5MG/ML)NoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
43066-031Verapamil Hydrochlorideverapamil hydrochlorideBaxter Healthcare CorporationANDACurrent
43066-031Verapamil Hydrochlorideverapamil hydrochlorideBaxter Healthcare CorporationANDACurrent
43066-031Verapamil Hydrochlorideverapamil hydrochlorideBaxter Healthcare CorporationANDACurrent
43066-031Verapamil Hydrochlorideverapamil hydrochlorideBaxter Healthcare CorporationANDACurrent
43066-035Verapamil Hydrochlorideverapamil HydrochlorideBaxter Healthcare CorporationANDACurrent
43066-035Verapamil Hydrochlorideverapamil HydrochlorideBaxter Healthcare CorporationANDACurrent
43066-035Verapamil Hydrochlorideverapamil HydrochlorideBaxter Healthcare CorporationANDACurrent
43066-035Verapamil Hydrochlorideverapamil HydrochlorideBaxter Healthcare CorporationANDACurrent
65145-113Verapamil HydrochlorideVerapamil HydrochlorideCaplin Steriles LimitedANDACurrent
65145-114Verapamil HydrochlorideVerapamil HydrochlorideCaplin Steriles LimitedANDACurrent